Ciprofloxacin Treatment for Colitis

Introduction

Ciprofloxacin is used to treat colitis, with varying efficacy in different types of colitis, and is recommended as adjunctive therapy in ulcerative colitis when added to conventional therapy with mesalamine and prednisone, although the strength of evidence is limited 1

The standard adult dose of ciprofloxacin for treating colitis is 500 mg orally twice daily for 7-14 days, depending on severity and clinical response, with an alternative extended-release formulation (1000 mg once daily) for improved compliance 2, 3

For children, the recommended dose of ciprofloxacin is 10-20 mg/kg/dose orally every 12 hours, with a maximum dose of 750 mg per dose orally, and for IV administration, the recommended dose is 10 mg/kg/dose every 8-12 hours, with a maximum IV dose of 400 mg per dose 2, 4

Ciprofloxacin should only be used when local resistance rates are known to be less than 10%, and alternative antibiotics should be considered in areas with higher fluoroquinolone resistance, as recommended by the American College of Gastroenterology and other guideline societies 1, 3, 5
Ciprofloxacin is effective for perianal disease but has limited evidence for luminal disease in Crohn's disease, and is recommended for perianal fistulae in Crohn's disease at a dose of 500 mg twice daily 6
Ciprofloxacin should be avoided in pregnancy due to teratogenic effects 5
Monitoring is recommended, including blood glucose in diabetic patients due to the risk of hypoglycemia, and ECG monitoring at baseline and after 2 weeks in patients with risk factors for QT prolongation, with a target trough level of 1 mg/L and peak level of 3 mg/L for doses of 500 mg twice daily 7

QT prolongation is a rare but serious adverse effect, especially with other QT-prolonging medications, and regular drug level monitoring is not necessary but may be performed in certain cases 7